Medtronic plc (0Y6X.L)
USD 80.71
(-1.1%)
USD 80.71
(-1.1%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 89.98 Billion USD | -1.06% |
| 2022 | 90.94 Billion USD | -0.04% |
| 2021 | 90.98 Billion USD | -2.26% |
| 2020 | 93.08 Billion USD | 2.64% |
| 2019 | 90.68 Billion USD | 1.11% |
| 2018 | 89.69 Billion USD | -1.86% |
| 2017 | 91.39 Billion USD | -8.48% |
| 2016 | 99.85 Billion USD | 0.21% |
| 2015 | 99.64 Billion USD | -6.6% |
| 2014 | 106.68 Billion USD | 181.17% |
| 2013 | 37.94 Billion USD | 8.72% |
| 2012 | 34.9 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 89.74 Billion USD | -0.26% |
| 2023 Q4 | 89.98 Billion USD | -0.94% |
| 2023 FY | 89.98 Billion USD | -1.06% |
| 2023 Q1 | 90.77 Billion USD | -0.19% |
| 2023 Q3 | 90.83 Billion USD | 0.83% |
| 2023 Q2 | 90.08 Billion USD | -0.76% |
| 2022 Q3 | 94.13 Billion USD | 0.96% |
| 2022 Q1 | 89.91 Billion USD | -1.17% |
| 2022 FY | 90.94 Billion USD | -0.04% |
| 2022 Q4 | 90.94 Billion USD | -3.38% |
| 2022 Q2 | 93.24 Billion USD | 3.7% |
| 2021 Q1 | 91.8 Billion USD | -1.38% |
| 2021 Q3 | 91.8 Billion USD | 0.05% |
| 2021 Q4 | 90.98 Billion USD | -0.9% |
| 2021 Q2 | 91.75 Billion USD | -0.05% |
| 2021 FY | 90.98 Billion USD | -2.26% |
| 2020 Q1 | 93.9 Billion USD | 3.55% |
| 2020 FY | 93.08 Billion USD | 2.64% |
| 2020 Q2 | 95.88 Billion USD | 2.11% |
| 2020 Q3 | 97.27 Billion USD | 1.44% |
| 2020 Q4 | 93.08 Billion USD | -4.3% |
| 2019 FY | 90.68 Billion USD | 1.11% |
| 2019 Q3 | 92.82 Billion USD | 1.94% |
| 2019 Q2 | 91.05 Billion USD | -0.24% |
| 2019 Q1 | 91.26 Billion USD | 1.75% |
| 2019 Q4 | 90.68 Billion USD | -2.3% |
| 2018 Q3 | 88.73 Billion USD | 0.66% |
| 2018 Q2 | 88.15 Billion USD | -1.75% |
| 2018 Q1 | 89.72 Billion USD | -1.84% |
| 2018 FY | 89.69 Billion USD | -1.86% |
| 2018 Q4 | 89.69 Billion USD | 1.09% |
| 2017 Q1 | 100.25 Billion USD | 0.3% |
| 2017 Q3 | 95.8 Billion USD | 1.42% |
| 2017 Q4 | 91.4 Billion USD | -4.59% |
| 2017 FY | 91.39 Billion USD | -8.48% |
| 2017 Q2 | 94.45 Billion USD | -5.78% |
| 2016 Q3 | 97.57 Billion USD | -0.84% |
| 2016 FY | 99.85 Billion USD | 0.21% |
| 2016 Q2 | 98.4 Billion USD | -0.2% |
| 2016 Q4 | 99.94 Billion USD | 2.43% |
| 2016 Q1 | 98.6 Billion USD | -1.05% |
| 2015 FY | 99.64 Billion USD | -6.6% |
| 2015 Q4 | 99.64 Billion USD | -2.98% |
| 2015 Q3 | 102.7 Billion USD | -2.13% |
| 2015 Q2 | 104.94 Billion USD | 0.3% |
| 2015 Q1 | 104.62 Billion USD | -1.93% |
| 2014 FY | 106.68 Billion USD | 181.17% |
| 2014 Q3 | 55.23 Billion USD | 42.43% |
| 2014 Q2 | 38.78 Billion USD | 3.26% |
| 2014 Q1 | 37.55 Billion USD | -1.03% |
| 2014 Q4 | 106.68 Billion USD | 93.15% |
| 2013 Q1 | 34.97 Billion USD | 0.21% |
| 2013 Q3 | 37.23 Billion USD | 2.09% |
| 2013 FY | 37.94 Billion USD | 8.72% |
| 2013 Q4 | 37.94 Billion USD | 1.91% |
| 2013 Q2 | 36.46 Billion USD | 4.28% |
| 2012 Q3 | 34.94 Billion USD | 0.0% |
| 2012 FY | 34.9 Billion USD | 0.0% |
| 2012 Q4 | 34.9 Billion USD | -0.14% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Phreesia, Inc. | 371.08 Million USD | -24148.083% |
| Accuray Incorporated | 468.62 Million USD | -19100.985% |
| Align Technology, Inc. | 6.08 Billion USD | -1379.008% |
| Elevance Health Inc. | 108.92 Billion USD | 17.394% |
| AxoGen, Inc. | 196.82 Million USD | -45615.781% |
| Boston Scientific Corporation | 35.13 Billion USD | -156.093% |
| CVS Health Corporation | 249.72 Billion USD | 63.968% |
| Cardinal Health, Inc. | 45.12 Billion USD | -99.422% |
| Centene Corporation | 84.64 Billion USD | -6.309% |
| DaVita Inc. | 17.61 Billion USD | -410.691% |
| HCA Healthcare, Inc. | 56.21 Billion USD | -60.077% |
| Hologic, Inc. | 9.15 Billion USD | -882.754% |
| Humana Inc. | 47.06 Billion USD | -91.185% |
| IDEXX Laboratories, Inc. | 3.25 Billion USD | -2660.217% |
| Laboratory Corporation of America Holdings | 16.72 Billion USD | -438.0% |
| Masimo Corporation | 3.04 Billion USD | -2858.442% |
| McKesson Corporation | 67.44 Billion USD | -33.418% |
| Patterson Companies, Inc. | 2.96 Billion USD | -2930.62% |
| Quest Diagnostics Incorporated | 14.02 Billion USD | -541.713% |
| ResMed Inc. | 6.87 Billion USD | -1209.311% |
| Henry Schein, Inc. | 10.57 Billion USD | -751.045% |
| Teladoc Health, Inc. | 4.39 Billion USD | -1948.576% |
| Universal Health Services, Inc. | 14.35 Billion USD | -526.746% |
| Veeva Systems Inc. | 5.91 Billion USD | -1422.284% |
| Baxter International Inc. | 28.27 Billion USD | -218.224% |
| Becton, Dickinson and Company | 52.78 Billion USD | -70.483% |
| Intuitive Surgical, Inc. | 15.44 Billion USD | -482.722% |
| Danaher Corporation | 84.48 Billion USD | -6.502% |
| Stryker Corporation | 39.91 Billion USD | -125.448% |